Evaluation of the Physiodoloris Pain Monitor in Patients With Complex Regional Pain Syndrome (ANI-ALGO)

H

Hopital Foch

Status

Completed

Conditions

Complex Regional Pain Syndrome

Treatments

Drug: Ropivacaine 0.5%

Study type

Interventional

Funder types

Other

Identifiers

NCT02663284
2011-A01676-35 (Other Identifier)
2011/67

Details and patient eligibility

About

A French University team (M. Jeanne, MD, and M. LOGIER, Ph D) have developed a pain assessment tool based on the analysis of the variability heart rate which evaluates the Analgesia Nociception Index (ANI). This index is intended to give a quantification of pain. The aim of the present study is to assess the validity of the ANI parameter in patients with Complex Regional Pain Syndrome treated with a nerve block (reversible pain).

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients suffering from a Complex Regional Pain Syndrome of the upper or lower limb

Exclusion criteria

  • contra-indication of a nerve block,
  • contra-indication of the use of the pain monitor

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Perineural block
Experimental group
Description:
Perineural block with Ropivacaine 0.5%
Treatment:
Drug: Ropivacaine 0.5%

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems